To the Editor, Burkitt lymphoma (BL) is a rapidly proliferative mature B-cell lymphoma for which cure depends on prompt initiation of effective multiagent immunochemotherapy.1 In Central Europe, newly diagnosed adult BL has traditionally been treated with German Multicenter Study Group for Adult Acute Lymphoblastic Leukeamia (GMALL) based high-intensity protocols, supported by the GMALL-B-ALL/NHL2002 trial, the largest prospective study conducted in adult BL/leukaemia and a benchmark dataset...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Florian
Contact Florian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack